Spero Therapeutics, Inc. Income Taxes Paid, Net
Spero Therapeutics, Inc. (SPRO) reported Income Taxes Paid, Net of -$2.21 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2023-11-13
- 2023-09-30: Income Taxes Paid, Net 9 month -$2.21M.
- 2022-09-30: Income Taxes Paid, Net 9 month $0.00.
| Period end | Income Taxes Paid, Net 9 month |
|---|---|
| 2023-09-30 | -$2.21M 10-Q · filed 2023-11-13 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |